Delivery Order SPE2DB20D2104-SPE2DB26FMBJQ
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,958.79 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,008.18 firm fixed-price delivery order on August 25, 2025, for Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a non-set-aside contract with an ultimate completion date of August 26, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $6,163.17 delivery order to AmerisourceBergen Drug Corp for 250 milliliters of Oxcarbazepine 300 milligrams per 5 milliliters suspension, with a completion date of September 16, 2025. The award was made on a firm fixed price basis with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee for this pharmaceutical supply delivery order. This delivery order is a child...
- The Defense Logistics Agency awarded a $1,088 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), a neurological medication commonly used to treat seizure disorders and neuropathic pain. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,155.65 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication commonly used in neurological treatment regimens. This firm fixed price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250ml quantities, with a ceiling value of $1,442.97. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,036.14 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of June 18, 2025, to be performed at the vendor's facility in Conshohocken, Pennsylvania. Oxcarbazepine is a neurological medication commonly used to treat seizure disorders and neuropathic pain conditions,...
- On September 3, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,791.77 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery...
- This delivery order, awarded September 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Oxcarbazepine 300 mg/5 ml suspension in a 250 ml quantity with a ceiling value of $1,125.28. The award is unset-aside and competitively awarded under a firm fixed price structure, with an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...